Ludmila M. Savchenko

The correlation between CYP2D6 isoenzyme activity and haloperidol efficacy and safety profile in patients with alcohol addiction during the exacerbation of the addiction

M. S. Zastrozhin, Ludmila M. Savchenko, Evgeny Bryun · Pharmacogenomics and Personalized Medicine · 2016 · 25 citations · Full text

Effects of CYP2D6 genetic polymorphisms on the efficacy and safety of fluvoxamine in patients with depressive disorder and comorbid alcohol use disorder

M. S. Zastrozhin, Valentin Yurievich Skryabin, Dmitrii D. Markov et al. · Pharmacogenomics and Personalized Medicine · 2018 · 24 citations · Full text

Genotyping and phenotyping of CYP2D6 and CYP3A isoenzymes in patients with alcohol use disorder: correlation with haloperidol plasma concentration

M. S. Zastrozhin, N. V. Baymeeva, Kristina Ryzhikova et al. · Drug Metabolism and Personalized Therapy · 2017 · 21 citations

The influence of CYP3A5 polymorphisms on haloperidol treatment in patients with alcohol addiction

M. S. Zastrozhin, Kristina Anatolievna Ryzhikova, Ludmila M. Savchenko et al. · Pharmacogenomics and Personalized Medicine · 2017 · 14 citations · Full text